Haemonetics Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Millions EUR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 20, 2026	Mar '25 Mar 29, 2025	Mar '24 Mar 30, 2024	Apr '23 Apr 1, 2023	Apr '22 Apr 2, 2022	Apr '21 Apr 3, 2021
Market Capitalization	2,414	2,931	4,018	3,842	2,957	4,843
Market Cap Growth	-29.72%	-27.06%	4.57%	29.95%	-38.95%	5.76%
Enterprise Value	3,145	3,827	4,644	4,341	3,451	4,956
Last Close Price	51.50	57.50	78.50	75.50	56.50	93.00
PE Ratio	16.19	18.93	36.87	36.17	75.24	71.65
PS Ratio	2.15	2.33	3.31	3.57	3.29	6.54
PB Ratio	3.12	3.87	4.51	5.10	4.36	7.78
P/TBV Ratio	-	-	-	54.93	-	-
P/FCF Ratio	9.22	22.29	30.18	51.08	43.08	79.34
P/OCF Ratio	8.38	17.47	23.85	15.29	18.95	52.33
EV/Sales Ratio	2.81	3.05	3.83	4.04	3.84	6.69
EV/EBITDA Ratio	10.15	11.65	16.96	18.72	19.87	31.60
EV/EBIT Ratio	14.31	16.78	24.23	28.21	36.22	58.21
EV/FCF Ratio	12.01	29.10	34.89	57.71	50.28	81.19
Debt / Equity Ratio	1.34	1.56	0.91	1.02	1.12	1.08
Debt / EBITDA Ratio	3.36	3.49	2.86	3.28	4.14	4.02
Debt / FCF Ratio	3.98	9.01	6.08	10.16	11.07	10.98
Net Debt / Equity Ratio	0.95	1.19	0.72	0.67	0.77	0.81
Net Debt / EBITDA Ratio	2.36	2.74	2.35	2.16	3.02	3.23
Net Debt / FCF Ratio	2.80	6.85	4.83	6.67	7.64	8.30
Asset Turnover	0.53	0.59	0.63	0.62	0.54	0.56
Inventory Turnover	1.54	1.71	2.07	1.98	1.50	1.49
Quick Ratio	1.04	0.88	1.29	1.85	0.95	1.26
Current Ratio	1.75	1.62	2.56	3.06	1.71	2.74
Return on Equity (ROE)	19.30%	18.83%	13.22%	14.72%	5.86%	12.05%
Return on Assets (ROA)	6.45%	6.65%	6.26%	5.51%	3.57%	4.05%
Return on Invested Capital (ROIC)	11.27%	11.33%	10.62%	10.14%	5.40%	8.96%
Return on Capital Employed (ROCE)	13.30%	13.20%	10.90%	9.90%	7.40%	6.40%
Earnings Yield	6.18%	5.28%	2.71%	2.76%	1.33%	1.40%
FCF Yield	10.85%	4.49%	3.31%	1.96%	2.32%	1.26%
Buyback Yield / Dilution	6.04%	1.30%	0.04%	-0.13%	-0.12%	1.01%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.